This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reddel, R. R. Articles by Sutherland, R. L. Search for Related Content PubMed PubMed Citation Articles by Reddel, R. R. Articles by Sutherland, R. L.

Factors Affecting the Sensitivity of T-47D Human Breast Cancer Cells to Tamoxifen

Ludwig Institute for Cancer Research (Sydney Branch), Blackburn Building, University of Sydney, Sydney, New South Wales 2006, Australia

Cell proliferation kinetics during growth of an estrogen receptor-positive human breast carcinoma cell line, T-47D, was defined, and some factors which modify its response to tamoxifen were investigated in vitro. T-47D cells were estrogen responsive when grown in charcoal-stripped fetal calf serum, but the addition of 17ß-estradiol did not fully restore the growth rate to that observed in the same concentration of fetal calf serum.

Tamoxifen had both a low-dose, estrogen-reversible, growth-inhibitory effect and a high-dose, estrogen-irreversible, growth-inhibitory and cytotoxic effect on T-47D cells. Tamoxifen-induced growth inhibition was associated with a decrease in the percentage of S-phase cells and, to a lesser extent, G₂-M-phase cells and an increase in G₀-G₁-phase cells. Plateau-phase cells were considerably less sensitive than were exponentially growing cells, and this was accompanied by a fall in unoccupied estrogen receptor content from 4407 ± 655 (S.E.) sites/cell in exponentially growing cultures to 1420 ± 315 sites/cell in plateau-phase cultures. T-47D cells were more sensitive to tamoxifen cytostasis when grown in fetal calf serum rather than charcoal-stripped fetal calf serum. However, with both types of growth medium, the sensitivity to tamoxifen was inversely related to the serum concentration, e.g., the 50%-inhibitory dose concentration increased 75-fold as the fetal calf serum concentration was increased from 0.25 to 10%. Addition of insulin to the culture medium had no effect on the growth rate, estrogen receptor content, or tamoxifen sensitivity of T-47D cells.

These results illustrate that the conditions under which cells are cultured markedly affect their sensitivity to tamoxifen and highlight the need to specify these conditions when reporting effects of this drug.

¹ To whom requests for reprints should be addressed.

Received 9/20/83. Accepted 3/ 6/84.

This article has been cited by other articles:

				A. M. Fowler, N. M. Solodin, C. C. Valley, and E. T. Alarid Altered Target Gene Regulation Controlled by Estrogen Receptor-{alpha} Concentration Mol. Endocrinol., February 1, 2006; 20(2): 291 - 301. [Abstract] [Full Text] [PDF]

				A. M. FOWLER, N. SOLODIN, M. T. PREISLER-MASHEK, P. ZHANG, A. V. LEE, and E. T. ALARID Increases in estrogen receptor-{alpha} concentration in breast cancer cells promote serine 118/104/106-independent AF-1 transactivation and growth in the absence of estrogen FASEB J, January 1, 2004; 18(1): 81 - 93. [Abstract] [Full Text] [PDF]

				E. T. Alarid, N. Bakopoulos, and N. Solodin Proteasome-Mediated Proteolysis of Estrogen Receptor: A Novel Component in Autologous Down-Regulation Mol. Endocrinol., September 1, 1999; 13(9): 1522 - 1534. [Abstract] [Full Text]

				K. D. Burroughs, K. Kiguchi, S. R. Howe, R. Fuchs-Young, D. Trono, J. C. Barrett, and C. Walker Regulation of Apoptosis in Uterine Leiomyomata Endocrinology, July 1, 1997; 138(7): 3056 - 3064. [Abstract] [Full Text] [PDF]

				M. T. Preisler-Mashek, N. Solodin, B. L. Stark, M. K. Tyriver, and E. T. Alarid Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E891 - E898. [Abstract] [Full Text] [PDF]